Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis. Am J Hematol 2024 Aug;99(8):1624-1627
Date
05/21/2024Pubmed ID
38769663DOI
10.1002/ajh.27354Scopus ID
2-s2.0-85193730657 (requires institutional sign-in at Scopus site)Author List
Alsouqi A, Ahmed G, Wang J, Cassanello G, Szabo A, Rojek AE, Riedell PA, Awan F, Samples L, Shadman M, Hu M, Bachanova V, Wesson W, Ahmed N, Iqbal M, Kharfan-Dabaja MA, Scordo M, Johnson PC, Chen YB, Ito S, Hamadani M, Frigault MAuthors
Mehdi H. Hamadani MD Professor in the Medicine department at Medical College of WisconsinAniko Szabo PhD Professor in the Data Science Institute department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AdultAged
Central Nervous System Neoplasms
Female
Humans
Immunotherapy, Adoptive
Lymphoma
Male
Middle Aged
